# T-Cell Therapy for Advanced Breast Cancer

> **NCT02792114** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 186 (actual)

## Conditions studied

- Breast Cancer
- Metastatic HER2-negative Breast

## Interventions

- **DRUG:** Cyclophosphamide
- **BIOLOGICAL:** Mesothelin-targeted T cells
- **DRUG:** AP1903

## Key facts

- **NCT ID:** NCT02792114
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2025-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792114, "T-Cell Therapy for Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02792114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*